post-divestiture.
BAXTER INTERNATIONAL INC.
Key Product Line Sales by US and International
Periods Ending September 30, 2007 and 2006
(unaudited)
($ in millions)
Q3 2007 Q3 2006(1)
----------------------------------------------------------
US International Total US International Total
----------------------------------------------------------
BioScience
Recombinants(2) $205 $227 $432 $182 $207 $389
Plasma Proteins
(3) 101 145 246 87 127 214
Antibody Therapy 178 67 245 146 50 196
Regenerative
Medicine(4) 44 38 82 40 32 72
Other(5) 28 66 94 13 83 96
----------------------------------------------------------
Total BioScience
(6) $556 $543 $1,099 $468 $499 $967
----------------------------------------------------------
Medication Delivery
IV Therapies(7) $109 $237 $346 $103 $214 $317
Global
Injectables(8) 217 155 372 210 140 350
Infusion Systems 123 84 207 118 79 197
Anesthesia(9) 75 36 111 53 23 76
Other(10) 4 7 11 5 5 10
----------------------------------------------------------
Total Medication
Delivery $528 $519 $1,047 $489 $461
'/>"/>
| SOURCE Baxter International Inc. Copyright©2007 PR Newswire. All rights reserved |